Lung cancer is one of the most common diseases in China, and its morbidity and mortality rank first among all cancers. Cancer treatment has entered a new era, and more and more cancer patients are benefiting from immunotherapy. At this stage, the COVID-19 epidemic situation seems to be grim. In order to better serve patients, we vigorously promote "Internet +" online services, effectively solve the lung cancer diagnosis and treatment problems encountered in various clinical departments through online discussion, better summarize experience, improve treatment level, build an academic platform, and benefit more medical staff and patients. On March 28, 2024, Chengdu High-tech Medical Association successfully held the 2024 "Lung Growth Together - Lung Cancer Precision Diagnosis and Treatment Forum (Phase 3)" online. The participating experts covered dozens of experts in respiratory and tumor fields inside and outside the province. All the participating experts carried out an inspiring collision of ideas in the form of academic meetings and case sharing.

This conference provides a platform for the majority of clinicians and researchers to exchange diagnosis and treatment technology and academic research results, which is conducive to promoting academic discussion and exchange of classic cases and cutting-edge technologies of lung cancer, and establishing the concept of comprehensive medical treatment and standardized treatment of lung cancer. It is of great significance to promote the high quality clinical research and promote the level of clinical research in the field of medical lung cancer.